In one study of a 67-year-old man with primary central nervous system lymphoma (PCNSL), after a second relapse, it was decided to proceed with chemotherapy with lymphodepletion followed by infusion of fourth generation CD19-CAR and CD70-CAR T-cells (4SCART19 and 4SCART70). The gene discussed is CD70; the disease is primary central nervous system lymphoma.